Skip to main content

4-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)morpholine

ADVERTISEMENT
Identification
Molecular formula
C17H22N2O
CAS number
258824-03-2
IUPAC name
4-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)morpholine
State
State

At room temperature, this compound is typically a solid, reflecting its molecular structure that favors crystallization under standard conditions.

Melting point (Celsius)
180.00
Melting point (Kelvin)
453.15
Boiling point (Celsius)
450.00
Boiling point (Kelvin)
723.15
General information
Molecular weight
270.37g/mol
Molar mass
270.3670g/mol
Density
1.2500g/cm3
Appearence

The compound typically appears as a crystalline solid at room temperature. The coloration may range from white to off-white, depending on purity and form.

Comment on solubility

Solubility of 4-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)morpholine

Understanding the solubility of 4-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)morpholine involves recognizing various key factors. This compound exhibits a unique structure that can influence its solubility in different solvents. Here are some essential points to consider:

  • Polarity: The presence of certain functional groups can enhance or inhibit solubility. This compound contains morpholine, which is typically polar, suggesting potential solubility in polar solvents.
  • Hydrogen Bonding: The ability of the molecule to form hydrogen bonds can significantly affect its solubility. This characteristic may promote solubility in water and alcohols.
  • Solvent Interactions: Generally, compounds tend to dissolve in solvents that have similar properties. The solubility of this compound can be pronounced in solvents like dimethyl sulfoxide (DMSO) as well as ethanol, but may be limited in non-polar solvents.

Overall, while specific experimental data would provide a clearer picture, it can be inferred that 4-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)morpholine is likely soluble in a range of polar solvents due to its polar functional groups and potential for hydrogen bonding. As a result, it may not readily dissolve in non-polar mediums, highlighting the importance of selecting the appropriate solvent for practical applications.

Interesting facts

Interesting Facts about 4-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)morpholine

This intriguing compound, known as a tetrahydrocycloheptaquinoline derivative, showcases a fascinating blend of structural complexity and potential applications in medicinal chemistry. Here are some key aspects that highlight its significance:

  • Structural Diversity: The compound features a unique bicyclic structure that includes both a cycloheptane and a quinoline moiety. This diversity contributes to its potential biological activity.
  • Pharmacological Potential: Compounds with similar structures are often investigated for their effects on the central nervous system, and may exhibit properties that modulate neurotransmitter activity.
  • Biological Relevance: The presence of morpholine in the structure enhances the compound's solubility and bioavailability, characteristics that are crucial for pharmaceutical applications.
  • Synthetic Challenges: The synthesis of such compounds can be quite complex, often involving multiple reaction steps and conditions. This challenges chemists to develop innovative synthetic routes.
  • Research Interest: Researchers are captivated by compounds like this due to their potential to inspire new drug discovery avenues, particularly in treating neurological disorders or providing new anti-cancer agents.

In summary, 4-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yl)morpholine is not just a chemical structure; it embodies the intersection of chemistry, biology, and medicinal research. As scientists continue to explore its properties and potential applications, it stands as a testament to the creativity and complexity that characterizes the world of chemical compounds.

Synonyms
4-(4-Morpholinyl)-2,3-pentamethylenequinoline
5839-57-6
BRN 1136460
6H-Cyclohepta(b)quinoline, 11-morpholino-7,8,9,10-tetrahydro-
DTXSID90207102
Compound 65-127
6H-CYCLOHEPTA(b)QUINOLINE, 7,8,9,10-TETRAHYDRO-11-MORPHOLINO-
6H-Cyclohepta(b)quinoline, 7,8,9,10-tetrahydro-11-(4-morpholinyl)-, monohydrochloride
DTXCID50129593